Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

Affiliations

• ¹ Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
• ² Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Palo Alto, CA (E.F.L.).
• ³ Duke University Medical Center, Durham, NC (C.B.G.).
• ⁴ Rigshospitalet, Blegdamsvej, University of Copenhagen, Denmark (L.K.).
• ⁵ ANMCO Research Center, Florence, Italy (A.P.M.).
• ⁶ Washington University School of Medicine, St. Louis, MO (D.L.M.).
• ⁷ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Scotland (J.J.V.M., M.C.P.).
• ⁸ Montréal Heart Institute, University of Montréal, Quebec, Canada (J.-L.R.).
• ⁹ Université de Paris, AP-HP (Assistance Publique-Hôpitaux de Paris), FACT (French Alliance for Cardiovascular Trials) and INSERM U-1148, France (P.G.S.).
• ¹⁰ Academic Research Organization - Hospital Israelita Albert Einstein, São Paulo-SP, Brazil (O.B.).
• ¹¹ Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Croatia (M.C.).
• ¹² Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia (C.G.D.P.).
• ¹³ Cardiology Service, Sanatorio Modelo Quilmes, Argentina (A.F.).
• ¹⁴ HF Unit at the Attikon University Hospital, Athens, Greece (G.F.).
• ¹⁵ Department of Cardiology, Charité University Medicine Berlin, German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin Institute of Health, Germany (U.L.).
• ¹⁶ Cardiovascular Medicine, Cleveland Clinic, OH (V.M.).
• ¹⁷ Semmelweis University, Heart and Vascular Center, Budapest, Hungary (B.M.).
• ¹⁸ Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria (I.P.).
• ¹⁹ Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark (M. Schou).
• ²⁰ Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy (M. Senni).
• ²¹ National Heart Centre Singapore (D.S.).
• ²² Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (P.v.d.M.).
• ²³ Novartis Pharmaceutical Corporation, East Hanover, NJ (M.L., Y.Z., Y.W.).
• ²⁴ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (E.B.).